RxDoctor Payments Data

Hasan Ali

Gastroenterology · Newark, DENPI 1427064260

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 282 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 52.5% of the total. Reporting peaked in 2022 at $2,118 and has fallen 74.1% since, to $549 in 2025.

$5,938in general payments, 2019–2025

Across 282 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$812
  • Johnson & Johnson$538
  • Takeda Pharmaceuticals U.S.A., Inc.$483
  • Abbott$308
  • Pfizer$109
  • plus $568 from 14 others

What the payments were for

  • Food & beverage$5,90899%
  • Education$301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,938 in reported general payments places this provider in the 65th percentile of 50 gastroenterology providers in Delaware.

See all gastroenterology providers in Delaware

Other gastroenterology in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →